erf transcription factor Search Results


tfap2c  (Proteintech)
93
Proteintech tfap2c
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Tfap2c, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/TFAP2C+Antibody/pmc08985761-70-18-20
Average 93 stars, based on 1 article reviews
tfap2c - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier
tomato ap2/erf transcription factor superfamily  (TranScrip Partners)
90
TranScrip Partners tomato ap2/erf transcription factor superfamily
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Tomato Ap2/Erf Transcription Factor Superfamily, supplied by TranScrip Partners, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/tomato+ap2+erf+transcription+factor+superfamily/10__1016_slash_j__hpj__2022__01__002-272-2-4
Average 90 stars, based on 1 article reviews
tomato ap2/erf transcription factor superfamily - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
ap2/erf-erf or b3 transcription factors  (Aikang MedTech)
90
Aikang MedTech ap2/erf-erf or b3 transcription factors
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Ap2/Erf Erf Or B3 Transcription Factors, supplied by Aikang MedTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/ap2+erf+erf+or+b3+transcription+factors/pmc11956103-59-12-23
Average 90 stars, based on 1 article reviews
ap2/erf-erf or b3 transcription factors - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
pathogenesis-related transcriptional factor/erf, dnabinding cold acclimation protein wcor413 family, early ck response gene beta-galactosidase related protein  (InterPro Inc)
90
InterPro Inc pathogenesis-related transcriptional factor/erf, dnabinding cold acclimation protein wcor413 family, early ck response gene beta-galactosidase related protein
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Pathogenesis Related Transcriptional Factor/Erf, Dnabinding Cold Acclimation Protein Wcor413 Family, Early Ck Response Gene Beta Galactosidase Related Protein, supplied by InterPro Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/pathogenesis+related+transcriptional+factor+erf++dnabinding+cold+acclimation+protein+wcor413+family++early+ck+response+gene+beta+galactosidase+related+protein/pmc05821449__pone__0192170__s012-99-18-13
Average 90 stars, based on 1 article reviews
pathogenesis-related transcriptional factor/erf, dnabinding cold acclimation protein wcor413 family, early ck response gene beta-galactosidase related protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
erf/ap2 transcription factor family  (Schmid GmbH)
90
Schmid GmbH erf/ap2 transcription factor family
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Erf/Ap2 Transcription Factor Family, supplied by Schmid GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/erf+ap2+transcription+factor+family/pm25618823-78-27-31
Average 90 stars, based on 1 article reviews
erf/ap2 transcription factor family - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
erf transcription factors  (Refgen Technologies INC)
90
Refgen Technologies INC erf transcription factors
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Erf Transcription Factors, supplied by Refgen Technologies INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/erf+transcription+factors/pm37976306-265-20-30
Average 90 stars, based on 1 article reviews
erf transcription factors - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier
truncatula bhlh 19 transcription factor mttt8  (Medicago)
86
Medicago truncatula bhlh 19 transcription factor mttt8
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Truncatula Bhlh 19 Transcription Factor Mttt8, supplied by Medicago, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/erf+factor+transcription/pm41105622-344-31-30
Average 86 stars, based on 1 article reviews
truncatula bhlh 19 transcription factor mttt8 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier
erf-vii transcription factor (rap2.12 and/or rap2.3)  (TranScrip Partners)
90
TranScrip Partners erf-vii transcription factor (rap2.12 and/or rap2.3)
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Erf Vii Transcription Factor (Rap2.12 And/Or Rap2.3), supplied by TranScrip Partners, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/erf+transcription+factor/erf+vii+transcription+factor++rap2+12+and+or+rap2+3+/pm37572126-48-11-7
Average 90 stars, based on 1 article reviews
erf-vii transcription factor (rap2.12 and/or rap2.3) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


TFAP2C transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.

Journal: Frontiers in Oncology

Article Title: TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

doi: 10.3389/fonc.2022.862015

Figure Lengend Snippet: TFAP2C transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.

Article Snippet: The primary antibodies were as follows: SLC7A11 (1:1000, Abcam, USA, Cat. ab175186), GPX4 (1:1000, Abcam, USA, Cat. ab125066), TFAP2C (1:1000, Proteintech, China, Cat. 14572-1-AP), c-Myc (1:1000, Proteintech, Cat. 67447-1-Ig) and β-actin (1:1000, Proteintech, China, Cat. 66009-1-Ig).

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Transfection, Control, Over Expression, Binding Assay, ChIP-qPCR, Luciferase, Mutagenesis, CCK-8 Assay, Knockdown, Plasmid Preparation